Lamassu Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 4

Lamassu General Information

Description

Developer of small-molecule therapeutics intended to treat acute pancreatitis and cancer. The company is advancing multiple drug therapies through clinical trials, including a cancer treatment for tumors, and uses research processes and a patient-centric approach, enabling the biopharmaceutical sector to accelerate the development of treatments addressing severe and unmet medical needs.

Contact Information

Website
www.lamassubiotech.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2530 Meridian Parkway
  • Suite 300
  • Durham, NC 27713
  • United States
+1 (919)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • 2530 Meridian Parkway
  • Suite 300
  • Durham, NC 27713
  • United States
+1 (919)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lamassu Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private Completed Clinical Trials - Phase 2
4. Later Stage VC Completed Clinical Trials - Phase 2
3. Grant 03-Jun-2024 Completed Clinical Trials - Phase 2
2. Grant 07-Jul-2020 $1.58M $2.67M Completed Clinical Trials - Phase 2
1. Early Stage VC (Series A) 29-Apr-2020 $2.67M $2.67M Completed Startup
To view Lamassu’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Lamassu Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of small-molecule therapeutics intended to treat acute pancreatitis and cancer. The company is advancing multi
Drug Discovery
Durham, NC
3 As of 2020

Cerdanyola, Spain
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Lamassu Competitors (91)

One of Lamassu’s 91 competitors is Ability Pharma, a Private Equity-Backed company based in Cerdanyola, Spain.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ability Pharma Private Equity-Backed Cerdanyola, Spain
Genentech Formerly VC-backed South San Francisco, CA
Incyte Formerly VC-backed Wilmington, DE
Renova Therapeutics Venture Capital-Backed Carlsbad, CA
Sorrento Therapeutics Formerly VC-backed San Diego, CA
You’re viewing 5 of 91 competitors. Get the full list »

Lamassu Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 2

    Pending

  • Expiring in next 12 mo

Lamassu Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026151724-A1 Lipase inhibitor formulations and methods of using the same Pending 07-Jan-2025
WO-2026080417-A1 Methods for treating pancreatic disorders Pending 08-Oct-2024

Lamassu Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lamassu Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Cancer Institute Government
National Institutes of Health Government
National Institute of Diabetes and Digestive and Kidney Diseases Government
Mayo Clinic Ventures Corporate Venture Capital Minority
To view Lamassu’s complete investors history, request access »

Ready to get started?

Request a free trial

Lamassu FAQs

  • When was Lamassu founded?

    Lamassu was founded in 2018.

  • Where is Lamassu headquartered?

    Lamassu is headquartered in Durham, NC.

  • What is the size of Lamassu?

    Lamassu has 3 total employees.

  • What industry is Lamassu in?

    Lamassu’s primary industry is Drug Discovery.

  • Is Lamassu a private or public company?

    Lamassu is a Private company.

  • What is Lamassu’s current revenue?

    The current revenue for Lamassu is .

  • How much funding has Lamassu raised over time?

    Lamassu has raised $2.67M.

  • Who are Lamassu’s investors?

    National Cancer Institute, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, and Mayo Clinic Ventures have invested in Lamassu.

  • Who are Lamassu’s competitors?

    Ability Pharma, Genentech, Incyte, Renova Therapeutics, and Sorrento Therapeutics are some of the 91 competitors of Lamassu.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process